Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II randomized, double-blind trial of SYH2069 injection in non-diabetic overweight or obese adults
CTR20263199Phase 2Active
- Sponsor
- Beijing Kangchuanglian Biopharmaceutical Technology Research Center
- Start
- Sep 2026
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of SYH2069 in obesity, Overweight, sponsored by Beijing Kangchuanglian Biopharmaceutical Technology Research Center. Started Sep 2026; status: active.
02
Drugs
SYH2069
03
Conditions
obesityOverweight
Beyond the preview
Go deeper on CTR20263199.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20263199.